My Size, Inc. v. Mizrahi

193 F. Supp. 3d 327, 2016 U.S. Dist. LEXIS 77616, 2016 WL 3398405
CourtDistrict Court, D. Delaware
DecidedJune 15, 2016
DocketCiv. No. 15-1061-SLR
StatusPublished
Cited by4 cases

This text of 193 F. Supp. 3d 327 (My Size, Inc. v. Mizrahi) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
My Size, Inc. v. Mizrahi, 193 F. Supp. 3d 327, 2016 U.S. Dist. LEXIS 77616, 2016 WL 3398405 (D. Del. 2016).

Opinion

MEMORANDUM OPINION

ROBINSON, District Judge

I. INTRODUCTION

My Size Inc. (“plaintiff’) filed a verified complaint on September 9, 2015 in the Court of Chancery in the State of Delaware against defendants Moshe Mizrahi (“Mizrahi”), Amir Waldman (‘Waldman”), Israel Healthcare Ventures 2 LP Incorporated (“IHCV”), Eitan Nachum (“Nac-hum”), James Shaul (“Shaul”), Yoav Matan (“Matan”), Mazal Dahan (“Dahan”), Boris Vaynberg (“Vaynberg”), Yotam Zimerman (“Zimerman”), Noah Sofer (“Sofer”), Nir Novak (“Novak”), Shai Alexandroni (“Alex-androni”), Ben Zion Levi (“Levi”), and Yo-ram Sade (“Sade”) (collectively, “defendants”). (D.I. 1 at 3) On November 16, 2015, defendants removed the action to this court. (Id) Presently before the court is defendants’ motion to dismiss for lack of personal jurisdiction, improper venue, forum non conveniens, and for failure to state a claim pursuant to Rules 12(b)(2), (3), (6) of the Federal Rules of Civil Procedure and 28 U.S.C. § 1406(a).1 (D.I. 6) This court has jurisdiction pursuant to 28 U.S.C. §§ 1441(a) and 1446.

II. BACKGROUND

Plaintiff is a corporation, organized and existing under the laws of the State of Delaware, whose shares are traded exclusively on the Tel Aviv Stock Exchange in Israel. ,(D.I. 1, ex. A at ¶¶ 1, 24) Defendants are a collection of individuals and companies who bought and traded shares of My Size and Metamorefix Ltd. (“Meta-morefix”).2 (Id at 1-3) Defendant Mizrahi is the former director of My Size Inc., and resides in Israel. (Id. at ¶ 2) Defendant IHCV is a corporation incorporated in Israel.3 (Id at ¶ 4) Defendants Waldman, [330]*330Nachum, Shaul, Matan, Dahan, Vaynberg, Zimerman, Sofer, Novak, Alexandroni, Levi, and Sade are all individuals residing in Israel. (Id. at ¶¶ 3, 5-13,15-17)

This litigation centers around a set of transactions that started on June 5, 2011 with defendant IHCV acquiring shares of Metamorefix, a company developing technology to repair skin tissue. (D.I, 11 at 2) A second transaction occurred on June-30, 2011, when plaintiffs largest shareholder, Medgenesis Partners Ltd., transferred 1,095,295 shares of My Size stock to IHCV. (Id.) In the third and final transaction, plaintiff traded 8,009,009 shares of My Size to defendants Mizrahi, Waldman, IHCV, Nachum, Shaul, Matan, and Dahan (collectively the “Metamorefix shareholders”), and 859,889 shares of My Size to defendant IHCV, in exchange for 5,725,000 shares of Metamorefix (“the Contract”). (Id.)

The Contract is written in Hebrew, was negotiated and executed in Israel, and contains a forum selection- clause. (D.I. 7 at 3) Plaintiff alleges that the translated clause reads: “The law which applies to this agreement is the law of the State of Israel and the place of jurisdiction for the purpose of a jurisdiction clause is the courts of the district of Tel Aviv-Jaffa.” (D.I. 11 at 14) (emphasis added) On the other hand, defendants contend that the translated clause reads: “The law that shall govern this agreement is the law of the State of Israel and the place of jurisdiction for the purpose of a jurisdiction clause is the courts of the district of Tel Aviv-Jaffa District.” (D.I. 7 at 7) (emphasis added)

Plaintiff alleges that the Contract contains conditions whereby defendants Mizr-ahi and Waldman promised that they would either raise money for Metamorefix or fund the company with their own capital, but this promise was never fulfilled. (D.1.11 at 4-5) Instead, Mizrahi, Waldman, and the rest of the Metamorefix shareholders offered an investment in Metamorefix to defendants Vaynberg, Zimerman, Sofer, Novak, Northwind Investments Ltd., Alex-androni, Levi, Sade and Deadalus Automation BV (collectively the “Novak Group”) at a price much lower than the required valuation. (Id. at 5) As a result, My Size has lost nearly all of its own value. (Id. at 6) In sum, plaintiff alleges that defendants acted tortiously and fraudulently to generate profits for themselves. (Id. at 7)

Defendants are currently unable to trade their shares of My Size because of restrictive legends placed on the shares, (D.I. 7 at 5) A suit was filed on September 9, 2015 in the district court of Tel Aviv, Israel, to remove said legends, wherein plaintiff has asserted counterclaims resembling the claims in this action. (Id. at 6) An initial preliminary hearing was held on January 11, 2016, and a second preliminary hearing was held on March 22, '2016. Judge Chaled Kabub has ordered mutual discovery of documents and responses to written questionnaires. (D.I. 12 at 8) On March 27, 2016, My Size’s motion to grant partial verdict was denied. (Id.) A trial date for the Israeli suit is set for July 17, 2016. (Id.)

III. STANDARDS OF REVIEW

A. Personal Jurisdiction

Rule 12(b)(2) of the Federal Rules of Civil Procedure directs the court to dismiss a ease when the court lacks personal jurisdiction over defendant. Fed. R. Civ. P. 12(b)(2). When reviewing á motion to dismiss pursuant to Rule 12(b)(2), a court must accept as true all allegations of jurisdictional fact made by plaintiff and resolve all factual disputes in plaintiffs favor. Traynor v. Liu, 495 F.Supp.2d 444, 448 (D.Del.2007). Once a jurisdictional defense has been raised, plaintiff bears the [331]*331burden of establishing, with reasonable particularity, that sufficient minimum contacts have occurred between defendant and the forum to support jurisdiction. See Provident Nat'l Bank v. Cal. Fed. Sav. & Loan Ass’n, 819 F.2d 434, 437 (3d Cir. 1987). To meet this burden, plaintiff must produce “sworn affidavits or other competent evidence,” since a Rule 12(b)(2) motion “requires resolution of factual issues outside the pleadings.” Time Share Vacation Club v. Atlantic Resorts, Ltd., 735 F.2d 61, 67 n.9 (3d Cir.1984).4

B. Venue

Rule 12(b)(3) provides that a motion to dismiss may be made on the basis of improper venue. Fed.R.Civ.P. 12(b)(3). The purpose of venue, in most instances, “is to protect the defendant against the risk that a plaintiff will select an unfair or inconvenient place of trial.” Cottman Transmission Systems, Inc. v. Martino, 36 F.3d 291, 294 (3d Cir.1994). Title 28, § 1391(b) provides that a

[cjivil action ... may ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
193 F. Supp. 3d 327, 2016 U.S. Dist. LEXIS 77616, 2016 WL 3398405, Counsel Stack Legal Research, https://law.counselstack.com/opinion/my-size-inc-v-mizrahi-ded-2016.